BACE1 and Insulin resistance: While this review is mainly focused on BACE1, other approaches that target the mechanisms or pathways intersecting with insulin resistance and β-amyloidosis such as antidiabetic treatments are currently under preclinical and clinical investigations and have been reviewed in detail elsewhere (Corraliza-Gomez et al., 2025; Zheng et al., 2025).